Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Perceived strength of evidence among providers, by perceived degree of implementation

From: Evaluating implementation of methicillin-resistant Staphylococcus aureus (MRSA) prevention guidelines in spinal cord injury centers using the PARIHS framework: a mixed methods study

  n = 228
Frequency (%)
  Fully implemented Not fully implemented p value (chi-square)
Perceived strength of evidence for prevention of MRSA transmission in SCI/D patients for the following practices    
 Gloving and gowning before entry into a MRSA-positive patient’s room    <0.0001
  Very strong/strong 86 (89.58) 86 (65.15)  
  Neutral/weak/very weak/don’t know 10 (10.42) 46 (34.85)  
 Taking off gloves and gown before leaving a patient’s room.    0.0001
  Very strong/strong 88 (91.67) 94 (71.21)  
  Neutral/weak/very weak/don’t know 8 (8.33) 38 (28.79)  
 That anyone entering a MRSA-positive patient’s room should wear gown and gloves    <0.0001
  Very strong/strong 80 (83.33) 68 (51.52)  
  Neutral/weak/very weak/don’t know 16 (16.67) 64 (48.48)  
Perceived strength of evidence for handwashing to prevent the spread of resistant organisms (including MRSA) in SCI/D    
 Health care workers before and after patient contact    0.012
  Very strong/strong 90 (93.75) 109 (82.58)  
  Neutral/weak/very weak/don’t know 6 (6.25) 23 (17.42)  
 Visitors/family members before and after patient contact    0.001
  Very strong/strong 79 (82.29) 83 (62.88)  
  Neutral/weak/very weak/don’t know 17 (17.71) 49 (37.12)  
 SCI/D patients    0.004
  Very strong/strong 73 (76.04) 76 (57.58)  
  Neutral/weak/very weak/don’t know 23 (23.96) 56 (42.42)  
 SCI/D patients with poor hand function    0.044
  Very strong/strong 63 (65.63) 69 (52.27)  
  Neutral/weak/very weak/don’t know 33 (34.38) 63 (47.73)  
Perceived strength of evidence that supports the following practices in SCI/D units    
 Active surveillance at admission    0.002
  Very strong/strong 79 (82.29) 84 (63.64)  
  Neutral/weak/very weak/don’t know 17 (17.71) 48 (36.36)  
 Active surveillance at transfer to another unit    <0.0001
  Very strong/strong 76 (79.17) 69 (52.27)  
  Neutral/weak/very weak/don’t know 20 (20.83) 63 (47.73)  
 Active surveillance at discharge    0.0001
  Very strong/strong 76 (79.17) 72 (54.55)  
  Neutral/weak/very weak/don’t know 20 (20.83) 60 (45.45)  
 Active surveillance of wounds or pressure ulcers    0.0004
  Very strong/strong 73 (76.04) 70 (53.03)  
  Neutral/weak/very weak/don’t know 23 (23.96) 62 (46.97)  
 Rescreening during long admissions    <0.0001
  Very strong/strong 67 (69.79) 57 (43.18)  
  Neutral/weak/very weak/don’t know 29 (30.21) 75 (56.82)